Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?

BACKGROUND AND OBJECTIVES: This study describes preferences of German relapsed refractory multiple myeloma (RRMM) patients with novel proteasome inhibitor-based combination treatments. METHODS: Patients with a minimum age of 18 years and a diagnosis of RRMM were included. Their preferences were asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilke, Thomas, Mueller, Sabrina, Bauer, Sabine, Pitura, Silvia, Probst, Leona, Ratsch, Boris A, Salwender, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235009/
https://www.ncbi.nlm.nih.gov/pubmed/30519004
http://dx.doi.org/10.2147/PPA.S183187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235009/
https://www.ncbi.nlm.nih.gov/pubmed/30519004
http://dx.doi.org/10.2147/PPA.S183187

Ejemplares similares